Clinical Trials on Leukemia, Chronic Myelogenous
Total 37253 results
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous Leukemia (CML)
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
Hospital Universitario Dr. Jose E. GonzalezUnknownChronic Myelogenous LeukemiaMexico
-
NovartisCompletedLeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Thrombocytopenia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Ariad PharmaceuticalsCompletedChronic Myelogenous Leukemia | Hematologic MalignanciesUnited States
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsTerminatedChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Centre Hospitalier Universitaire de BesanconCompleted
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Mansoura UniversityCompletedCML, Chronic Phase | Chronic Myelogenous Leukemia, BCR-ABL PositiveEgypt
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMDS | Chronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML)United States
-
Novartis PharmaceuticalsCompletedLeukemia, Myeloid, ChronicIsrael
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia
-
University of California, IrvineRecruitingChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedPhiladelphia Positive (Ph+) Chronic Myelogenous LeukemiaUnited States, France, Korea, Republic of, Thailand, Italy, Netherlands, Turkey, Hungary, Russian Federation, Spain, United Kingdom, Japan, Malaysia
-
University Hospital, AngersCompletedSolid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)France
-
AbbVie (prior sponsor, Abbott)CompletedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | B-cell Chronic Lymphocytic Leukemia | MyelodysplasiaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Lymphocytic Leukemia | MDS (Myelodysplastic Syndrome) | CLL (Chronic Lymphocytic Leukemia) | CML (Chronic Myelogenous Leukemia) | AML (Acute Myelogenous Leukemia)United States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
University of TexasCompletedAcute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia | Myelodysplastic Syndrome (MDS) | CLL (Chronic Lymphocytic Leukemia) | CML (Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous LeukemiaCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Emory UniversityTerminatedRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaTurkey
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMinimal Residual Disease | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Ginna LaportTerminatedAcute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors | Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase | Myelodysplastic Syndrome (MDS) - High and Intermediate Risk | Non-Hodgkin's Lymphoma (NHL) | Chronic Lymphocytic Leukemia...United States
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Philadelphia Chromosome Negative Chronic Myelogenous... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)Completed
-
Columbia UniversityWithdrawn
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
III. Medizinische Klinik MannheimUnknownLeukemiaSwitzerland, Germany, Spain, Poland, Czech Republic
-
University of LiverpoolImperial College London; Newcastle University; University of GlasgowUnknownChronic Myeloid LeukaemiaUnited Kingdom
-
University Hospital, BordeauxCompleted
-
Bio-Path Holdings, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia, Ph1-PositiveUnited States
-
Novartis PharmaceuticalsCompletedMyelogenous Leukemia, ChronicSouth Africa, Italy, Belgium, Japan, Taiwan, Turkey, Canada, Germany, Spain, Egypt, United States, Singapore, Austria, France, Netherlands, Sweden, United Kingdom, Korea, Republic of, Hong Kong, Thailand, Russian Federation, Brazil, Hungar... and more
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
PETHEMA FoundationCompleted
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Samara State Medical UniversityRecruitingChronic Myeloid LeukaemiaRussian Federation